EGFR and non-small cell lung carcinoma: Epidermal growth factor receptor (EGFR) gene mutations are the most common driver oncogene mutations associated with non-small cell lung cancer (NSCLC), accounting for 55% of driver oncogene mutations in lung adenocarcinoma cases in East Asia [1].